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bilirubin concentration and ankle–brachial index were low
(o0.2). Those correlations were weak but significant
probably because of the large sample size of the study, as
Dr Kassimatis et al. pointed out.
The main outcome of this study was the negative
correlation between serum bilirubin concentration and
degree of urinary albumin excretion (r¼0.202,
Po0.0001), which is a useful marker of diabetic nephro-
pathy. The adjusted R-square was also low (R2¼ 0.222,
Po0.0001). However, to our surprise, the strength of
serum bilirubin concentration as an independent determi-
nant of log (urinary albumin excretion) was similar to
those of known factors such as systolic blood pressure,
HbA1c, and duration of diabetes in multiple regression
analysis.
We believe that serum bilirubin concentration could be
a protective marker for diabetic nephropathy and athero-
sclerosis in patients with type 2 diabetes. Large prospective
trials are needed to better assess the effects of bilirubin on
diabetic nephropathy and atherosclerosis in patients with
type 2 diabetes.
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To the Editor: We read with interest the article by Fukui
et al.1 showing that serum bilirubin was positively associated
with estimated glomerular filtration rate (e-GFR), and
negatively associated with albuminuria in 633 Japanese type
2 diabetic adults, thus suggesting a renoprotective effect of
bilirubin.
To further investigate the association between serum
bilirubin and kidney function, we performed a retrospective
analysis on the database of our laboratory to retrieve results
of fasting serum bilirubin, glucose, and creatinine tests that
were performed on consecutive adult outpatients (aged 435
years) referred by general practitioners for routine blood
testing over the last 6 months. Similarly to the Fukui et al.
study,1 patients with bilirubin 41.2 mg/100 ml or creatinine
42.0 mg/100 ml were excluded from the study.
Cumulative results for bilirubin and other variables were
retrieved for 2678 adult outpatients (mean age: 55±18 years;
43% male patients), 210 of whom had type 2 diabetes. Serum
bilirubin concentrations were negatively associated with
e-GFR levels, as estimated by the Modification of Diet in
Renal Disease equation, in both non-diabetic (r¼0.17;
Po0.0001) and diabetic patients (r¼0.14; Po0.05).
Accordingly, compared to participants with normal kidney
function, serum bilirubin concentrations were higher
(Po0.001) in those with e-GFR p60 ml/min per 1.73 m2
in both non-diabetic and diabetic groups, independent of age
and gender.
Our findings are in contrast to the results by Fukui et al.,1
and indicate that increased serum bilirubin concentrations,
even within the reference range, are significantly associated
with decreased kidney function in an unselected outpatient
cohort of Caucasian non-diabetic and diabetic adults.
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We would like to thank Targher et al.1 for the interest in
our article2 and the editor for the opportunity to clarify
the several points raised.
We are surprised to see their data, which are in contrast
to our result. We cannot be certain of the reason for this
disparity. The possible explanations for this disparity are
as follows. First, mean age (64±12 vs 55±18 years) and
the proportion of male gender (52 vs 43%), which were
determinants of estimated glomerular filtration rate, were
greater in our study compared to those in their study.
Second, serum bilirubin concentrations were significantly
associated with duration of diabetes, diastolic blood
pressure, and serum triglyceride concentration in our
study. The differences in those factors as well as in
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medication for diabetes, hypertension, and dyslipidemia
might cause this disparity. Serum bilirubin concentration
correlated positively with estimated glomerular filtration
rate, and serum bilirubin concentrations were lower
(P¼ 0.0126) in those with estimated glomerular filtration
rates below 60 ml/min per 1.73 m2 compared to patients
with normal kidney function independent of age and
gender in our study.
Based on in vitro as well as animal studies, bilirubin is
generally recognized as an important antioxidant sub-
stance. Kumar et al.3 demonstrated that serum bilirubin
concentration correlated inversely with a marker of
oxidative stress and correlated positively with antioxidative
enzyme activities such as superoxide dismutase, catalase,
and glutathione peroxidase. Besides being an antioxidant,
bilirubin also has anticomplement properties that protect
against inflammation.4 Furthermore, bilirubin has been
suggested to have cytoprotective properties through its
influence on protein kinase C.5 Through these mechan-
isms, bilirubin would protect diabetic patients from the
development and progression of diabetic nephropathy,6–9
and our data would be supported by these mechanisms.
1. Targher G, Zoppini G, Guidi GC et al. Relationship between serum
bilirubin and kidney function in non-diabetic and diabetic individuals.
Kidney Int 2009; 75: 863.
2. Fukui M, Tanaka M, Shiraishi E et al. Relationship between serum bilirubin
and albuminuria in patients with type 2 diabetes. Kidney Int 2008; 74:
1197–1201.
3. Kumar A, Pant P, Basu S et al. Oxidative stress in neonatal
hyperbilirubinemia. J Trop Pediatr 2007; 53: 69–71.
4. Nakagami T, Toyomura K, Kinoshita T et al. A beneficial role of bile
pigments as an endogenous tissue protector: anti-complement effects of
biliverdin and conjugated bilirubin. Biochim Biophys Acta 1993; 1158:
189–193.
5. Mietus-Synder M, Friera A, Glass CK et al. Regulation of scavenger
receptor expression in smooth muscle cells by protein kinase C: a role for
oxidative stress. Arterioscler Thromb Vasc Biol 1997; 17: 969–978.
6. Suzuki D, Miyata T, Saotome N et al. Immunohistochemical evidence for
an increased oxidative stress and carbonyl modification of proteins in
diabetic glomerular lesions. J Am Soc Nephrol 1999; 10: 822–832.
7. Roh DD, Kamanna VS, Kirschenbaum MA. Oxidative modification of low-
density lipoprotein enhances mesangial cell protein synthesis and gene
expression of extracellular matrix proteins. Am J Nephrol 1998; 18:
344–350.
8. Stehouwer CDA, Gall MA, Twisk JWR et al. Increased urinary albumin
excretion, endotherial dysfunction, and chronic low-grade inflammation
in type 2 diabetes. Diabetes 2002; 51: 1157–1165.
9. Koya D, King GL. Protein kinase C activation and the development of
diabetic complications. Diabetes 1998; 47: 859–866.
Michiaki Fukui1 and Naoto Nakamura1
1Department of Endocrinology and Metabolism, Kyoto Prefectural University
of Medicine, Graduate School of Medical Science, Kawaramachi-Hirokoji,
Kamigyo-ku, Kyoto, Japan
Correspondence: Michiaki Fukui, Department of Endocrinology and
Metabolism, Kyoto Prefectural University of Medicine, Graduate School of
Medical Science, 465 Kajii-cho, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto
602-8566, Japan. E-mail: sayarinapm@hotmail.com
864 Kidney International (2009) 75, 860–864
l e t t e r t o t h e e d i t o r
